Forte Capital Stock vs Total Assets Analysis

FBRX Stock  USD 16.00  0.36  2.30%   
Forte Biosciences financial indicator trend analysis is much more than just examining Forte Biosciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Forte Biosciences is a good investment. Please check the relationship between Forte Biosciences Capital Stock and its Total Assets accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.

Capital Stock vs Total Assets

Capital Stock vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Forte Biosciences Capital Stock account and Total Assets. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Forte Biosciences' Capital Stock and Total Assets is -0.35. Overlapping area represents the amount of variation of Capital Stock that can explain the historical movement of Total Assets in the same time period over historical financial statements of Forte Biosciences, assuming nothing else is changed. The correlation between historical values of Forte Biosciences' Capital Stock and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Stock of Forte Biosciences are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Capital Stock i.e., Forte Biosciences' Capital Stock and Total Assets go up and down completely randomly.

Correlation Coefficient

-0.35
Relationship DirectionNegative 
Relationship StrengthInsignificant

Capital Stock

The total amount of a company's capital funded by shareholders through the issue and subscription of shares.

Total Assets

Total assets refers to the total amount of Forte Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Forte Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Forte Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Forte Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.Selling General Administrative is likely to drop to about 7.6 M in 2024. Tax Provision is likely to drop to 855.00 in 2024
 2023 2024 (projected)
Depreciation And Amortization9K8.6K
Interest Income1.1M1.3M

Forte Biosciences fundamental ratios Correlations

0.520.550.640.830.7-0.06-0.740.570.330.69-0.040.32-0.381.00.92-0.240.83-0.380.45-0.150.840.740.60.71.0
0.520.790.590.030.670.62-0.560.56-0.340.90.710.87-0.320.490.320.310.68-0.320.9-0.630.560.70.910.670.49
0.550.790.930.130.770.35-0.810.74-0.090.840.380.62-0.450.520.250.180.47-0.450.58-0.290.650.750.820.770.52
0.640.590.930.310.750.2-0.840.750.040.70.090.4-0.580.620.350.130.49-0.580.41-0.130.710.680.720.750.62
0.830.030.130.310.35-0.49-0.530.240.60.25-0.44-0.15-0.220.850.88-0.620.54-0.22-0.080.170.620.460.060.350.85
0.70.670.770.750.350.06-0.770.970.230.880.130.32-0.040.680.540.210.48-0.040.620.090.530.760.771.00.68
-0.060.620.350.2-0.490.06-0.060.04-0.930.290.660.77-0.4-0.09-0.180.740.42-0.40.67-0.790.250.210.60.06-0.08
-0.74-0.56-0.81-0.84-0.53-0.77-0.06-0.73-0.13-0.70.11-0.270.32-0.72-0.60.08-0.530.32-0.310.0-0.73-0.9-0.57-0.78-0.73
0.570.560.740.750.240.970.04-0.730.210.780.050.190.00.550.390.30.320.00.520.220.460.670.70.970.55
0.33-0.34-0.090.040.60.23-0.93-0.130.210.04-0.49-0.540.310.350.37-0.7-0.180.31-0.380.68-0.020.02-0.280.230.35
0.690.90.840.70.250.880.29-0.70.780.040.520.68-0.140.660.480.150.62-0.140.8-0.310.650.790.890.880.67
-0.040.710.380.09-0.440.130.660.110.05-0.490.520.84-0.13-0.07-0.250.350.26-0.130.72-0.740.150.080.580.13-0.06
0.320.870.620.4-0.150.320.77-0.270.19-0.540.680.84-0.420.290.130.340.64-0.420.84-0.870.510.490.810.310.3
-0.38-0.32-0.45-0.58-0.22-0.04-0.40.320.00.31-0.14-0.13-0.42-0.38-0.18-0.04-0.561.0-0.190.58-0.57-0.15-0.38-0.04-0.39
1.00.490.520.620.850.68-0.09-0.720.550.350.66-0.070.29-0.380.93-0.260.82-0.380.42-0.130.830.730.570.681.0
0.920.320.250.350.880.54-0.18-0.60.390.370.48-0.250.13-0.180.93-0.30.78-0.180.31-0.030.670.680.370.540.93
-0.240.310.180.13-0.620.210.740.080.3-0.70.150.350.34-0.04-0.26-0.30.08-0.040.54-0.24-0.070.020.480.21-0.25
0.830.680.470.490.540.480.42-0.530.32-0.180.620.260.64-0.560.820.780.08-0.560.69-0.610.790.660.720.480.83
-0.38-0.32-0.45-0.58-0.22-0.04-0.40.320.00.31-0.14-0.13-0.421.0-0.38-0.18-0.04-0.56-0.190.58-0.57-0.15-0.38-0.04-0.39
0.450.90.580.41-0.080.620.67-0.310.52-0.380.80.720.84-0.190.420.310.540.69-0.19-0.610.440.540.930.620.42
-0.15-0.63-0.29-0.130.170.09-0.790.00.220.68-0.31-0.74-0.870.58-0.13-0.03-0.24-0.610.58-0.61-0.38-0.18-0.510.09-0.13
0.840.560.650.710.620.530.25-0.730.46-0.020.650.150.51-0.570.830.67-0.070.79-0.570.44-0.380.720.630.530.84
0.740.70.750.680.460.760.21-0.90.670.020.790.080.49-0.150.730.680.020.66-0.150.54-0.180.720.690.760.73
0.60.910.820.720.060.770.6-0.570.7-0.280.890.580.81-0.380.570.370.480.72-0.380.93-0.510.630.690.770.57
0.70.670.770.750.351.00.06-0.780.970.230.880.130.31-0.040.680.540.210.48-0.040.620.090.530.760.770.68
1.00.490.520.620.850.68-0.08-0.730.550.350.67-0.060.3-0.391.00.93-0.250.83-0.390.42-0.130.840.730.570.68
Click cells to compare fundamentals

Forte Biosciences Account Relationship Matchups

Forte Biosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets7.7M61.2M43.3M42.0M39.0M43.2M
Other Current Liab343.2K1.0M812K2.0M2.2M4.0M
Total Current Liabilities1.9M2.3M1.8M3.2M3.7M6.0M
Total Stockholder Equity(4.8M)59.0M41.5M38.8M35.3M42.2M
Property Plant And Equipment Net4.0M150.6K97K0.0109K103.6K
Net Debt1.8M(58.8M)(42.0M)(41.1M)(12.0M)(12.6M)
Retained Earnings(5.0M)(51.5M)(73.2M)(87.0M)(118.5M)(124.4M)
Accounts Payable1.6M1.2M946K1.2M1.4M1.3M
Cash6.9M58.8M42.0M41.1M12.0M11.4M
Non Current Assets Total150.6K1.3M786K486K653K620.4K
Other Assets227K1.4M0.01.00.90.86
Cash And Short Term Investments6.9M58.8M42.0M41.1M37.1M41.0M
Common Stock Total Equity20K23K1K13K11.7K9.9K
Common Stock Shares Outstanding2.1M294.4K558.7K695.3K1.3M862.0K
Short Term Investments52.8M55.3M12.8M25.2M22.6M29.7M
Liabilities And Stockholders Equity7.7M61.2M43.3M42.0M39.0M43.2M
Non Current Liabilities Total28.4M10.5M1.2M946K1.2M0.0
Other Current Assets53.2K1.1M476K411K1.2M831.3K
Other Stockholder Equity(10.3M)49.2M71.4M125.8M153.8M96.1M
Total Liab12.4M2.3M1.8M3.2M3.7M3.5M
Property Plant And Equipment Gross4.0M150.6K97K0.0118K112.1K
Total Current Assets7.5M59.9M42.5M41.5M38.3M41.8M
Accumulated Other Comprehensive Income10K(61.2M)(43.3M)4K3.6K3.8K
Common Stock23K1K13K21K36K37.8K
Property Plant Equipment1.2M4.0M152K97K87.3K82.9K
Net Tangible Assets(4.8M)59.0M41.5M38.8M44.6M29.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Forte Stock Analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.